Thalomid (thalidomide)

thalidomide · Celgene (now part of Bristol Myers Squibb)

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Thalomid (thalidomide), covering 2009-02-09 to 2016-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients [Phase 1, Phase 2]